Document:

Exhibit

Exhibit 10.1

R 
CRESTWOOD EQUITY PARTNERS LP
LONG-TERM INCENTIVE PLAN
 
PERFORMANCE UNIT GRANT AGREEMENT
 
THIS PERFORMANCE UNIT GRANT AGREEMENT (this “Agreement”), dated as of February 15, 2017, is made and entered into by and between Crestwood Equity GP LLC, a Delaware limited liability company (the “General Partner”), and ________ (the “Service Provider”).  Capitalized terms used in this Agreement but not otherwise defined herein shall have the meanings ascribed to such terms in the Plan (as defined below), unless the context requires otherwise. 
RECITALS
 
A.     Crestwood Equity Partners LP (the “Partnership”), acting through the Board of Directors of the General Partner (the “Board”), has adopted the Crestwood Equity Partners LP Long Term Incentive Plan (the “Plan”) to, among other things, attract, retain and motivate certain employees and directors of the Partnership, the General Partner and their respective Affiliates (collectively, the “Partnership Entities”); 

B.    The Plan provides for the grant of performance units, which are phantom (notional) rights that represent the right to receive one or more limited partnership units (a “Unit”) of the Partnership as determined by the Committee (as defined in the Plan).  

C.    The Plan also permits the granting of rights to receive an amount in cash or additional Units with respect to the cash distributions made by the Partnership with respect to a Unit during the period such performance unit is outstanding (“DERs”). 
 
D.     The Committee has decided to make a performance unit grant, with DERs, subject to the terms and conditions set forth in this Agreement and the Plan, as an inducement for the Participant to promote the best interests of the Partnership.  
 
NOW, THEREFORE, in consideration of the Service Provider’s agreement to provide or to continue providing services, the Service Provider and the General Partner agree as follows:
 
1.     Grant of Performance Units.  Subject to the terms and conditions set forth in this Agreement and the Plan, the General Partner hereby confirms the grant to the Service Provider of _____Performance Units (the “Performance Units”) as of the date set forth above (the “Date of Grant”).  The Performance Units will become vested in accordance with Paragraph 3 below and will be distributed in accordance with Paragraph 4 below.  Except as otherwise provided below, prior to the date the Performance Units are distributed as Units in accordance with Paragraph 4 below, the Service Provider will not be deemed to have any voting rights or cash distribution rights with respect to any Units subject to this grant.  For purposes of this Agreement, each Performance Unit shall be equivalent to one Unit.
 
2.    Performance Unit Account.  The General Partner shall establish and maintain a Performance Unit account, as a bookkeeping account on its records (the “Performance Unit Account”), for the Service Provider and shall record in such Performance Unit Account the number of Performance Units granted to the Service Provider pursuant to this Agreement and the cash value of DERs accrued from time to time.  The Service Provider shall not have any interest in any fund or specific assets of the Employer by reason of this grant or the Performance Unit Account established for, or DERs credited to, the Service Provider.
 
3.    Vesting.
 
(a)    Except as otherwise provided in subparagraphs (b), (c) and (d) below, the Service Provider will become vested in the Performance Units awarded pursuant to this Agreement three years after the Date of Grant (the 

“Restriction Period”) based on the achievement of performance goals with respect to the Partnership as described on the attached Exhibit A, provided the Service Provider does not incur a termination of employment or service with the Employer prior to the end of the Restriction Period.  The amount payable with respect to the Service Provider’s Performance Units shall be determined by multiplying each Performance Unit granted (including any Additional Performance Units) by a payout performance multiplier of between fifty percent and two hundred percent (50%-200%) (the “Performance Multiplier”), which shall be determined pursuant to and based upon actual performance compared to the performance goals described on Exhibit A.
 
(b)     Except as otherwise provided in this Agreement, if the Service Provider terminates his or her employment or service with the Employer prior to the end of the Restriction Period, the Performance Units credited to the Service Provider’s Performance Unit Account that have not vested as of the date of termination shall terminate and the corresponding Units shall be forfeited; provided, however, that if the Service Provider terminates employment or service with the Employer on account of death or Disability (as defined in the Plan), all of the Service Provider’s unvested Performance Units shall vest and be paid immediately based on a payout performance multiplier of one hundred percent (100%).
 
(c)     If the Service Provider terminates employment or service with the Employer as a result of a termination by the Employer without Cause (as defined in the Plan) of if a Change in Control (as defined in the Plan) occurs after the Date of Grant and while the Service Provider is employed by, or providing service to the Employer, the Performance Units will vest as follows:

		
	(i)
	if there are less than twelve months left prior to the end of the Restriction Period, the Performance Units credited to the Service Provider’s Performance Unit Account that have not vested will vest at the end of the Restriction Period at a multiple of the Performance Multiplier based on the actual performance results for the Restriction Period; and

		
	(ii)
	if there are twelve months or more left prior to the end of the Restriction Period, the Performance Units credited to the Service Provider’s Performance Unit Account that have not vested will vest on the date of the Service Provider’s termination of employment or service based on a payout multiplier of one hundred percent (100%). 

 
(d)    Notwithstanding any other provisions set forth in this Agreement or in the Plan, if the Service Provider ceases to be employed by, or provide service to, the Employer on account of a termination by the Employer for Cause, any Performance Units credited to the Service Provider’s Performance Unit Account that have not been distributed pursuant to Paragraph 4 as of such date shall immediately terminate and become null and void. 
 
4.    Distribution.  All of the Performance Units credited to the Service Provider’s Performance Unit Account that vest pursuant to Paragraph 3 above and Exhibit A shall become converted to Units to be issued under the Plan and shall be distributed as soon as practicable following, but no later than 30 days following, the date the Performance Units vest as set forth in this Agreement.
 
5.    DERs.  In the event the Partnership pays any distributions in respect of its outstanding Common Units and, on the record date for such distribution, the Service Provider holds Performance Units granted pursuant to this Agreement that have not vested and been settled (including Additional Performance Units, as defined in this Section 5, together with the unsettled Performance Units, the “Outstanding Performance Units”), the amount of such distribution that would be payable to the Service Provider if he or she were the holder of record of a number of Common Units equal to the number of Outstanding Performance Units (the “DER Payment”) shall be retained by the General Partner.  The DER Payment will be deemed invested in full (and, as applicable, fractional) Performance Units effective as of the last day of the Restriction Period.  Such additional Performance Units (the “Additional Performance Units”) will constitute Performance Units subject to the same vesting provisions (including the Performance Multiplier) and the restrictions and risk of forfeiture described in Section 3 of this Agreement.  The restrictions and risk of forfeiture imposed on the Additional Performance Units will lapse at the same time, and 

subject to the same conditions, as each Performance Unit (or Additional Performance Unit) upon which the distribution was paid.  The number of Additional Performance Units created pursuant to the declaration and payment of any distribution in respect of a Common Unit will be determined by dividing the DER Payment by the Fair Market Value of a Common Unit on the last day of the Restriction Period (or, if such day is not a Business Day, on the last Business Day preceding the last day of the Restriction Period).
 
6.    Acknowledgment by Service Provider.  By executing this grant, the Service Provider hereby acknowledges that with respect to any right to a distribution and DERs pursuant to this Agreement, the Service Provider is and shall be an unsecured creditor of the Partnership without any preference as against other unsecured general creditors of the Partnership, and the Service Provider hereby covenants for himself or herself, and anyone at any time claiming through or under the Service Provider, not to claim any such preference, and hereby disclaims and waives any such preference that may at any time be at issue, to the fullest extent permitted by applicable law.  The Service Provider also hereby agrees to be bound by the terms and conditions of the Plan and this Agreement.  The Service Provider further agrees to be bound by the determinations and decisions of the Committee with respect to this Agreement and the Plan and the Service Provider’s rights to benefits under this Agreement and the Plan, and agrees that all such determinations and decisions of the Committee shall be binding on the Service Provider, his or her beneficiaries and any other person having or claiming an interest under this Agreement and the Plan on behalf of the Service Provider.
 
7.    Restrictions on Issuance or Transfer of Units.  The obligation of the General Partner to deliver Units upon distribution of the Performance Units shall be subject to the condition that if at any time the Committee shall determine in its discretion that the listing, registration or qualification of the Units upon any securities exchange or under any state or federal law, or the consent or approval of any governmental regulatory body is necessary or desirable as a condition of, or in connection with, the issuance of the Units, the Units may not be issued in whole or in part unless such listing, registration, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Committee.  In the event an exemption from registration under the Securities Act of 1933 (the “Securities Act”) is available, the Service Provider, if requested by the General Partner to do so, will execute and deliver to the General Partner in writing an agreement containing such provisions as the General Partner may require to assure compliance with applicable securities laws.  No sale or disposition of Units acquired pursuant to this grant by the Service Provider shall be made in the absence of an effective registration statement under the Securities Act with respect to such Units unless an opinion of counsel satisfactory to the General Partner that such sale or disposition will not constitute a violation of the Securities Act or any other applicable securities laws is first obtained.
 
8.    Grant Subject to Plan Provisions.  This grant is made pursuant to the Plan, the terms of which are incorporated herein by reference, and in all respects shall be interpreted in accordance with the Plan.  In the event of any contradiction, distinction or difference between this Agreement and the terms of the Plan, the terms of the Plan will control.  This grant is subject to the interpretations, regulations and determinations concerning the Plan established from time to time by the Committee in accordance with the provisions of the Plan, including, but not limited to, provisions pertaining to (i) rights and obligations with respect to withholding taxes, (ii) the registration, qualification or listing of Units, (iii) changes in capitalization of the Partnership, and (iv) other requirements of applicable law.  The Committee shall have the authority to interpret and construe this Agreement pursuant to the terms of the Plan, and its decisions shall be conclusive as to any questions arising hereunder.  By receiving this grant, the Service Provider hereby agrees to be bound by the terms and conditions of the Plan and this Agreement.  The Service Provider further agrees to be bound by the determinations and decisions of the Committee with respect to this Agreement and the Plan and the Service Provider’s rights to benefits under this Agreement and the Plan and agrees that all such determinations and decisions of the Committee shall be binding on the Service Provider, his or her beneficiaries and any other person having or claiming an interest under this Agreement and the Plan on behalf of the Service Provider.
 
9.    Assignment and Transfers.  No Performance Units or DERs awarded to the Service Provider under this Agreement may be transferred, assigned, pledged or encumbered by the Service Provider, except (i) by will or by the laws of descent and distribution or (ii) pursuant to a domestic relations order.  Except as set forth above, any attempt to transfer, assign, pledge or encumber the Performance Units or DERs by the Service Provider shall be null, void and without effect.  The rights and protections of the General Partner hereunder shall extend to any successors or assigns of General Partner.

 
10.    Taxes/Withholding.  The vesting of Performance Units, as well as any amounts received upon distribution of Performance Units pursuant to Paragraph 4 above, and the payment of Units for any DERs, is treated as taxable income to the Service Provider, subject to withholding, and the Service Provider shall be solely responsible for all tax consequences that result from the vesting and distribution of the Performance Units, as well as any subsequent sale of Units and the payment of cash with respect to DERs.  The Employer is authorized to withhold from any payment due or transfer made under this grant or from any compensation or other amount owing to the Service Provider, the amount (in cash or Units that would otherwise be issued pursuant to this grant as determined by the Committee) of any applicable withholding taxes that are due in respect of this grant, the lapse of restrictions thereon, or any payment or transfer under this grant and to take such other action as may be necessary in the opinion of the Employer to satisfy its withholding obligations for the payment of such taxes.  If Units are withheld, the maximum number of Units that may be withheld will be the number of Units that have an aggregate Fair Market Value on the date of withholding no greater than the aggregate amount of such tax liabilities of the Service Provider determined based on the greatest withholding rates for federal, state, foreign and/or local tax purposes, including payroll taxes, that may be utilized without creating adverse accounting treatment with respect to the Performance Units, as determined by the Committee.
 
11.    No Rights as Unitholder.  The Service Provider shall not have any rights as a Unitholder of the Partnership, including the right to any cash distributions, or the right to vote, with respect to any Performance Units.
 
12.    Employment Not Affected.  This grant of Performance Units and DERs shall not confer upon the Service Provider any right to be retained by, or in the employ or service of, the Employer and shall not interfere in any way with the right of the Employer to terminate the Service Provider’s employment or service at any time.  The right of the Employer to terminate at will the Service Provider’s employment or service at any time for any reason is specifically reserved.
 
13.    Effect on Other Benefits.  The value of Units and DERs distributed with respect to the Performance Units shall not be considered eligible earnings for purposes of any other plans maintained by the Employer.  Neither shall such value be considered part of the Service Provider’s compensation for purposes of determining or calculating other benefits that are based on compensation, such as life insurance.
 
14.    Amendments.  The General Partner may waive any conditions or rights under and amend any terms of this Agreement, provided that no change shall materially reduce the benefit to the Service Provider without the consent of the Service Provider, except as necessary to comply with the requirements of Paragraph 17 below.
 
15.    Governing Law.  The validity, construction, interpretation and effect of this Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to the conflict of laws provisions thereof, and applicable federal law.
 
16.      Notice.  Any notice to the General Partner provided for in this Agreement shall be addressed to the General Partner in care of the General Counsel at the principal office of the General Partner, and any notice to the Service Provider shall be addressed to such Service Provider at the current address shown in the records of the Employer, or to such other address as the Service Provider may designate to the Employer in writing.  Any notice shall be delivered by hand, sent by telecopy or enclosed in a properly sealed envelope addressed as stated above, registered and deposited, postage prepaid, in a post office regularly maintained by the United States Postal Service.
 
17.    Section 409A of the Internal Revenue Code.  This Agreement is intended to comply with an exemption to section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), and the regulations promulgated thereunder.  To the extent that any provision of this Agreement or the Plan would cause a conflict with the requirements of section 409A of the Code, such provision shall be deemed null and void to the extent permitted by applicable law.  This Agreement may be amended without the consent of the Service Provider in any respect deemed by the Committee to be necessary in order to preserve compliance with section 409A of the Code.  If the Service Provider is a “specified employee” within the meaning of Treasury Regulation § 1.409A-1(i) as of the date of the Service Provider’s separation from service, the Service Provider shall not be entitled to any payment or benefit pursuant to Paragraph 3(c)(ii) until the earlier of (i) the date which is six (6) months after his or her separation from service for any reason other than death, or (ii) the date of the Service Provider’s death.  The 

provisions of this paragraph shall only apply if, and to the extent, required to avoid the imputation of any tax, penalty or interest pursuant to Section 409A of the Code.  Phrases regarding to the termination or separation of the Service Provider’s employment or service relationship with the Partnership Entities mean a “separation from service” within the meaning of Treasury Regulation § 1.409A-1(h).

18.    Consent to Electronic Delivery; Electronic Signature. In lieu of receiving documents in paper format, the Service Provider agrees, to the fullest extent permitted by law, to accept electronic delivery of any documents that the Partnership may be required to deliver (including, without limitation, prospectuses, prospectus supplements, grant or award notifications and agreements, account statements, annual and quarterly reports, and all other forms of communications) in connection with this and any other award made or offered by the Partnership. Electronic delivery may be via a Partnership electronic mail system or by reference to a location on a Partnership intranet to which the Service Provider has access.  The Service Provider hereby consents to any and all procedures the Partnership has established or may establish for an electronic signature system for delivery and acceptance of any such documents that the Partnership may be required to deliver, and agrees that his or her electronic signature is the same as, and shall have the same force and effect as, his or her manual signature.  Emailed or faxed signatures (or copies thereof) on this Agreement shall be valid, binding and as effective as original signatures for all purposes.
 
[SIGNATURES APPEAR ON FOLLOWING PAGE]
 

IN WITNESS WHEREOF, this Agreement has been duly executed as of the dates set forth below.
 
 
	
			
	 
	BY APPROVAL OF THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS OF CRESTWOOD EQUITY GP LLC:

	 
	 

	 
	Crestwood Equity Partners LP

	 
	By: Crestwood Equity GP LLC, as its general partner

	 
	 

	 
	By:
	 

	 
	 
	Joel C. Lambert

	 
	 Senior Vice President, General Counsel &

	 
	 Secretary

	 
	 

	 
	Date: February 15, 2017

 
I hereby accept the Performance Units and DERs described in this Agreement, and I agree to be bound by the terms of the Plan and this Agreement.  I hereby further agree that all of the decisions and interpretations of the Committee with respect to this Agreement and the Plan shall be final and binding.
 
 
	
				
	 
	Service Provider:
	 

	 
	 
	 

	 
	 

	 
	Date:
	 

	 
	 
	 
	 

 
7Exhibit 101

		

			Exhibit 10.1

		

		

			Execution Version

		

		

			 

		

		

			 

		

		
			SECURITIES PURCHASE AGREEMENT
		

		
			 
		

		
			THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of May 3, 2017, by and among Aratana Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on Schedule A attached hereto (each, a “Purchaser,” and collectively, the “Purchasers”).
		

		
			 
		

		
			WHEREAS, the Company has prepared and filed with the Securities and Exchange Commission (the “SEC”), in accordance with the provisions of the Securities Act of 1933, as amended (the “Securities Act”), and the applicable rules and regulations thereunder, a registration statement on Form S-3 (File No. 333-197414), including a prospectus, relating to the shares to be issued and sold pursuant to this Agreement. The term “Registration Statement” as used herein refers to such registration statement (including all financial schedules and exhibits), as amended or as supplemented and includes information contained in the form of final prospectus and supplements thereto (the “Prospectus”) filed with the SEC pursuant to Rule 424(b) of the rules under the Securities Act and deemed to be part thereof at the time of effectiveness (the “Effective Date”) pursuant to Rule 430B of the rules under the Securities Act; and
		

		
			 
		

		
			WHEREAS, the Company intends to pay Barclays Capital Inc. (the “Placement Agent”) a fee in respect of the sale of Shares (as defined below) to the Purchasers, and the Company has entered into a Placement Agency Agreement (the “Placement Agency Agreement”) with Barclays Capital Inc. that contains certain customary representations, warranties, covenants and agreements of the Company for the benefit of the Placement Agent alone.
		

		
			﻿
		

		
			NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:
		

		
			 
		

		
			ARTICLE I
		

		
			PURCHASE AND SALE
		

		
			 
		

		
			1.1 Closing. Each Purchaser agrees to purchase from the Company, and the Company agrees to issue and sell to such Purchaser, a number of shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), equal to such Purchaser’s subscription amount as set forth on Schedule A attached hereto (the “Subscription Amount”) divided by the Purchase Price (as defined below).  Upon satisfaction of the conditions set forth in Section 1.3, the closing of the purchase and sale of the Shares  (the “Closing”) shall occur at the offices of the Company on May 9, 2017, or at such other place or on such other date as the parties shall mutually agree. By executing this Agreement, each Purchaser consents and agrees to any later date and time for the Closing agreed to by the Company and the Placement Agent.
		

		
			 
		

		
			1.2 Per Share Purchase Price. The purchase price for the Shares shall be equal to $5.25 per share (the “Purchase Price”).
		

		
			 
		

		

		

		 

 

		1.3 Closing Conditions.
		

		
			 
		

		
			(a) As a condition to each Purchaser’s obligation to consummate the transactions contemplated hereby, at the Closing, the Company shall have satisfied each of the conditions set forth below or shall deliver or cause to be delivered to each Purchaser the items set forth below, as appropriate:
		

		
			﻿
		

		
			(i) this Agreement duly executed by the Company;
		

		
			 
		

		
			(ii) within five (5) business days of the Closing, a certificate evidencing the Shares, registered in the name of such Purchaser (unless such shares have been previously issued to such Purchaser through the book-entry facilities of The Depository Trust Company);
		

		
			﻿
		

		
			(iii) the representations and warranties made by the Company herein shall be true and correct in all material respects on the date hereof and on the date of the Closing;
		

		
			﻿
		

		
			(iv) all covenants, agreements and conditions contained in this Agreement to be performed by the Company on or prior to the date of the Closing shall have been performed or complied with in all material respects;
		

		
			﻿
		

		
			(v) no statute, regulation, executive order, decree, ruling or injunction shall have been enacted, promulgated, endorsed or threatened or is pending by or before any governmental authority of competent jurisdiction which prohibits or threatens to prohibit the consummation of the transaction contemplated by this Agreement; and
		

		
			 
		

		
			(vi) the Company shall have filed an application with The Nasdaq Stock Market for the listing of the Shares.
		

		
			﻿
		

		
			(b) As a condition to the Company’s obligation to consummate the transactions contemplated hereby, at the Closing, each Purchaser shall have satisfied each of the conditions set forth below or shall deliver or cause to be delivered to the Company the items set forth below, as appropriate:
		

		
			 
		

		
			(i) this Agreement duly executed by such Purchaser;
		

		
			 
		

		
			(ii) the Subscription Amount by wire transfer of immediately available funds to the account of the Company as set forth on Schedule A hereto;
		

		
			 
		

		
			(iii) the representations and warranties made by such Purchaser herein shall be true and correct in all material respects on the date hereof and on the date of the Closing;
		

		
			 
		

		
			(iv) such Purchaser shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by such Purchaser at or before the Closing; and
		

		
			 
		

		

		

		 

		

			2

		

		

			 

		

 

		(v) no statute, regulation, executive order, decree, ruling or injunction shall have been enacted, promulgated, endorsed or threatened or is pending by or before any governmental authority of competent jurisdiction which prohibits or threatens to prohibit the consummation of the transaction contemplated by this Agreement.
		

		
			 
		

		
			(c) As of the date of the Closing, there shall have been no Material Adverse Effect (as defined below) with respect to the Company since the date hereof.
		

		
			 
		

		
			ARTICLE II
REPRESENTATIONS AND WARRANTIES
		

		
			 
		

		
			2.1 Representations and Warranties of the Company. Except as set forth in the Company’s filings under the Securities Exchange Act of 1934, as amended, the Company hereby makes the following representations and warranties as of the date hereof and as of the date of the Closing to Purchasers:
		

		
			 
		

		
			(a) Organization and Qualification. The Company is an entity duly incorporated, validly existing and in good standing under the laws of the State of Delaware, with the requisite corporate power and authority to own and use its properties and assets and to carry on its business as currently conducted. The Company is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by the Company makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, would not have or reasonably be expected to result in (i) a material adverse effect on the legality, validity or enforceability of this Agreement, (ii) a material adverse effect on the results of operations, assets, business or financial condition of the Company, or (iii) a material adverse effect on the Company’s ability to perform in any material respect on a timely basis its obligations under this Agreement (any of (i), (ii) or (iii), a “Material Adverse Effect”).
		

		
			 
		

		
			(b) Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and otherwise to carry out its obligations hereunder. The execution and delivery of this Agreement by the Company and the consummation by it of the transactions contemplated hereby have been duly authorized by all necessary corporate action on the part of the Company and no further action is required by the Company in connection therewith. This Agreement has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally and (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies.
		

		
			 
		

		
			(c) No Conflicts. The execution, delivery and performance of this Agreement by the Company and the consummation by the Company of the transactions contemplated hereby do not and will not (i) conflict with or violate any provision of the Company’s Restated Certificate of Incorporation or Amended and Restated Bylaws, or (ii) conflict with, or constitute a default (or an 
		

		 

		

			3

		

		

			 

		

 

		event that with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company debt or otherwise) or other understanding to which the Company is a party or by which any property or asset of the Company is bound or affected, or (iii) result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company is bound or affected; except in the case of each of clauses (ii) and (iii), such as would not have or reasonably be expected to result in a Material Adverse Effect.
		

		
			 
		

		
			(d) Filings, Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other person in connection with the execution, delivery and performance by the Company of this Agreement, other than (i) the filing with the SEC of a Form 8-K and prospectus supplement relating to the Registration Statement, and applicable Blue Sky filings, if any, and (ii) such as have already been obtained.
		

		
			 
		

		
			(e) Authorization of the Shares. The Shares, when issued at the Closing in accordance with the terms of this Agreement, will be, duly authorized, validly issued, fully paid and nonassessable, and free and clear of all liens created by the Company.
		

		
			﻿
		

		
			(f) Registration Statement. The Registration Statement has become effective under the Securities Act, and no stop order suspending the effectiveness of the Registration Statement is in effect, and no proceedings for such purpose are pending before or threatened by the SEC.
		

		
			﻿
		

		
			2.2 Representations and Warranties of Purchasers. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the date hereof and as of the date of the Closing to the Company as follows:
		

		
			 
		

		
			(a) Organization; Authority. If Purchaser is not a natural person, such Purchaser is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization with full right, corporate, limited liability or partnership power and authority to enter into and to consummate the transactions contemplated by this Agreement and otherwise to carry out its obligations hereunder. The execution, delivery and performance by Purchaser of the transactions contemplated by this Agreement has been duly authorized by all necessary corporate or similar action on the part of Purchaser. This Agreement to which it is a party has been duly executed by Purchaser, and when delivered by Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of Purchaser, enforceable against it in accordance with its terms except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally and (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies.
		

		
			 
		

		

		

		 

		

			4

		

		

			 

		

 

		(b) Information; Confidentiality. Purchaser and its advisors, if any, have been furnished with all publicly available materials relating to the business, finances and operations of the Company and such other publicly available materials relating to the offer and sale of the Shares as have been requested by Purchaser. Purchaser and its advisors, if any, have been afforded the opportunity to ask questions of the Company. Neither such inquiries nor any other due diligence investigations conducted by Purchaser or its advisors, if any, or its representatives shall modify, amend or affect such Purchaser’s right to rely on the Company’s representations and warranties contained herein. Purchaser understands that its investment in the Shares involves a high degree of risk. Purchaser has sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to its acquisition of the Shares.  Other than to other persons party to this Agreement or to such Purchaser’s representatives, including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). 
		

		
			﻿
		

		
			(c) No Governmental Review. Purchaser understands that no United States federal or state agency or any other government or governmental agency has passed on or made any recommendation or endorsement of the Shares or the fairness or suitability of the investment in the Shares, nor have such authorities passed upon or endorsed the merits of the offering of the Shares.
		

		
			﻿
		

		
			(d) Sales; Short Selling. From and after the date Purchaser received any information about the existence of this offering, Purchaser has not offered, pledged, sold, contracted to sell, sold any option or contract to purchase, purchased any option or contract to sell, granted any option, right or warrant to purchase, loaned, or otherwise transferred or disposed of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock, entered into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Common Stock, or directly or indirectly, through related parties, affiliates or otherwise sold “short” or “short against the box” (as those terms are generally understood) any equity security of the Company. Purchaser covenants that it will not, nor will it authorize or permit any person acting on its behalf to, engage in any such transactions until following the Closing.
		

		
			 
		

		
			(e) Information Regarding Purchaser. Purchaser has provided the Company with true, complete, and correct information regarding all applicable items with respect to such Purchaser on Schedule A to this Agreement.
		

		
			 
		

		
			(f) Placement Agents as Beneficiaries. Purchaser expressly acknowledges and agrees that all representations, warranties, covenants and agreements made or given by the Purchaser to the Company herein, are also irrevocably made and given for the benefit of the Placement Agent and that the Placement Agent is entitled to rely on the same in connection with the placement of the Shares as if such representations, warranties, covenants and agreements, as applicable, were made directly to the Placement Agent.
		

		
			 
		

		
			(g) Non-Reliance on Placement Agents. Purchaser understands that the Placement Agent has acted solely as the agent of the Company in this placement of the Shares and not to the 
		

		 

		

			5

		

		

			 

		

 

		Purchaser. Purchaser further acknowledges that (i) the Placement Agent, its affiliates, and its respective representatives make no representation or warranty with regard to the merits of the offering of the Shares or as to the completeness or accuracy of any information or materials such Purchaser may have received in connection therewith, and Purchaser has not relied and will not rely on any information, representations or advice furnished by or on behalf of any of the Placement Agent, its affiliates or its respective representatives, orally or in writing, in making a decision to purchase the Shares, (ii) it will be responsible for conducting its own due diligence investigation with respect to the Company and the offer and sale of the Shares, (iii) it will be purchasing Shares based on the results of its own due diligence investigation of the Company and (iv) it has negotiated the offer and sale of the Shares directly with the Company, and the Placement Agent will not be responsible for the ultimate success of any such investment.
		

		
			 
		

		
			ARTICLE III
		

		
			MISCELLANEOUS
		

		
			 
		

		
			3.1 Fees and Expenses. Each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement.
		

		
			 
		

		
			3.2 Entire Agreement. This Agreement, together with the exhibits and schedules thereto, contains the entire understanding of the parties with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.
		

		
			 
		

		
			3.3 Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered via facsimile prior to 6:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile on a day that is not a Trading Day or later than 6:30 p.m. (New York City time) on any Trading Day, (c) the Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications is set forth on the Company signature page attached hereto in the case of the Company, and shall be supplementally provided in writing in the case of each Purchaser. For purposes of this Agreement, “Trading Day” shall mean a day on which the Company’s Common Stock is traded on the Nasdaq National Market, or, if the Company’s Common Stock is not eligible for trading on the Nasdaq National Market, any day except Saturday, Sunday and any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.
		

		
			 
		

		
			3.4 Amendments; Waivers. No provision of this Agreement may be waived or amended except in a written instrument signed, in the case of an amendment, by the Company and Purchaser or, in the case of a waiver, by the party against whom enforcement of any such waiver is sought. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a 
		

		 

		

			6

		

		

			 

		

 

		waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of either party to exercise any right hereunder in any manner impair the exercise of any such right.
		

		
			 
		

		
			3.5 Construction. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. 
		

			
					
						﻿

					
					
						 

					
					
						 

				

		
			3.6 Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. Neither Company nor the Purchasers may assign this Agreement or any rights or obligations hereunder without the prior written consent of the other party.
		

		
			 
		

		
			3.7 Termination. In the event that the Placement Agency Agreement is terminated by the Placement Agent pursuant to the terms thereof, this Agreement shall terminate without any further action or obligation on the part of the parties hereto.
		

		
			 
		

		
			3.8 Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York.
		

		
			 
		

		
			3.9 Survival. The representations, warranties, agreements and covenants contained herein shall survive the Closing and delivery of the Shares.
		

		
			 
		

		
			3.10 Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile signature page were an original thereof.
		

		
			 
		

		
			3.11 Severability. If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Agreement.
		

		
			 
		

		
			3.12 Replacement of Securities. If any certificate or instrument evidencing any of the Shares is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction and customary and reasonable indemnity, if requested. The applicants for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs associated with the issuance of such replacement certificate.
		

		
			 
		

		

		

		 

		

			7

		

		

			 

		

 

		3.13 Exculpation of the Placement Agents. The Company and each Purchaser agrees for the express benefit of the Placement Agent, its affiliates and its respective representatives that:
		

		
			 
		

		
			(a) None of the Placement Agent, its affiliates or its representatives: (i) have any duties or obligations under this Agreement; (ii) shall be liable for any improper payment made in accordance with this Agreement and the information provided herein by the Company; (iii) make any representation or warranty, or have any responsibilities as to the validity, accuracy, value or genuineness of any information, certificates or documentation delivered by or on behalf of the Company pursuant to this Agreement; or (iv) shall be liable (x) for any action taken, suffered or omitted by any of them in good faith and reasonably believed to be authorized or within the discretion or rights or powers conferred upon it by this Agreement or (y) for anything which any of them may do or refrain from doing in connection with this Agreement, except for such party’s own gross negligence or willful misconduct or required by law.
		

		
			 
		

		
			(b) The Placement Agent, its affiliates and its respective representatives shall be entitled to rely on, and shall be protected in acting upon, any certificate, instrument, opinion, notice, letter or any other document or security delivered to any of them by or on behalf of the Company.
		

		
			 
		

		
			(Signature Pages Follow)
		

		

		

		 

		

			8

		

		

			 

		

 

		

			 

		

		IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.
		

		
			 
		

			
					
						﻿

					
					
						 

					
					
						 

				
	
					
						Aratana Therapeutics, Inc.

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						By:

					
					
						/s/ Steven St. Peter

					
					
						 

				
	
					
						Name:

					
					
						 Steven St. Peter

					
					
						 

				
	
					
						Title:

					
					
						President & CEO

					
					
						 

				

		
			﻿
		

		
			 
		

		
			Address for Notice:
		

		
			11400 Tomahawk Creek Parkway, Suite 340
		

		
			Leawood, Kansas 66211
		

		
			Attn: John C. Ayres
		

		
			Tel: (913) 353-1003
		

		
			 
		

		
			With a copy to (which shall not constitute notice):
		

		
			 
		

		
			Latham & Watkins LLP
		

		
			200 Clarendon Street, 27th Floor
		

		
			Boston, Massachusetts 02116
		

		
			Attn: Peter N. Handrinos
		

		
			Tel: (617) 948-6060
		

		
			Fax: (617) 948-6001
		

		
			 
		

		
			[Company Signature Page to Securities Purchase Agreement]
		

		

		

		 

		

			 

		

 

		

			 

		

		IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.
		

		
			 
		

		
			Name of Purchaser:    Janus Investment Fund – Janus Venture Fund             
		

		
			Signature of Authorized Signatory of Purchaser:        /s/ Jonathan Coleman                      
		

		
			Name of Authorized Signatory:        Jonathan Coleman                     
		

		
			Title of Authorized Signatory:         Portfolio Manager                    
		

		
			Email Address of Authorized Signatory:       xxxxx@xxxx.com        
		

		
			﻿
		

		
			[Purchaser Signature Page to Securities Purchase Agreement]
		

		
			﻿
		

		

		

		 

		

			 

		

 

		

			 

		

		
		

		
			IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.
		

		
			 
		

		
			Name of Purchaser:    Janus Capital Funds Plc – Janus Venture Fund             
		

		
			Signature of Authorized Signatory of Purchaser:        /s/ Jonathan Coleman                      
		

		
			Name of Authorized Signatory:        Jonathan Coleman                     
		

		
			Title of Authorized Signatory:         Portfolio Manager                    
		

		
			Email Address of Authorized Signatory:       xxxxx@xxxx.com        
		

		
			﻿
		

		
			[Purchaser Signature Page to Securities Purchase Agreement]
		

		
			﻿
		

		
			﻿
		

		

		

		 

		

			 

		

 

		

			 

		

		
		

		
			IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.
		

		
			 
		

		
			Name of Purchaser:    Deutsche Asset Management   (DWS US Growth)         
		

		
			Signature of Authorized Signatory of Purchaser:        /s/ Dr. Sebastian P. Werner                     
		

		
			Name of Authorized Signatory:        Dr. Sebastian P. Werner                     
		

		
			Title of Authorized Signatory:         Portfolio Manager, Director             
		

		
			Email Address of Authorized Signatory:       xxxxx@xxxx.com        
		

		
			﻿
		

		
			[Purchaser Signature Page to Securities Purchase Agreement]
		

		
			﻿
		

		
			﻿
		

		

		

		 

		

			 

		

 

		

			 

		

		
		

		
			IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.
		

		
			 
		

		
			Name of Purchaser:    EcoR1 Capital Fund Qualified, LP         
		

		
			Signature of Authorized Signatory of Purchaser:        /s/ Oleg Nodelman                     
		

		
			Name of Authorized Signatory:        Oleg Nodelman                     
		

		
			Title of Authorized Signatory:         Managing Member, EcoR1 Capital LLC, as GP             
		

		
			Email Address of Authorized Signatory:       xxxxx@xxxx.com        
		

		
			﻿
		

		
			[Purchaser Signature Page to Securities Purchase Agreement]
		

		
			﻿
		

		
			﻿
		

		

		

		 

		

			 

		

 

		

			 

		

		
		

		
			IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.
		

		
			 
		

		
			Name of Purchaser:    EcoR1 Capital Fund, LP         
		

		
			Signature of Authorized Signatory of Purchaser:        /s/ Oleg Nodelman                     
		

		
			Name of Authorized Signatory:        Oleg Nodelman                     
		

		
			Title of Authorized Signatory:         Managing Member, EcoR1 Capital LLC, as GP             
		

		
			Email Address of Authorized Signatory:       xxxxx@xxxx.com        
		

		
			﻿
		

		
			[Purchaser Signature Page to Securities Purchase Agreement]
		

		

		

		 

		

			 

		

 

		

			 

		

		
		

		
			IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.
		

		
			 
		

		
			Name of Purchaser:    Ohio National Fund, Inc. – Small Cap Growth Portfolio         
		

		
			Signature of Authorized Signatory of Purchaser:       /s/ Jonathan Coleman                      
		

		
			Name of Authorized Signatory:        Jonathan Coleman                     
		

		
			Title of Authorized Signatory:         Portfolio Manager                    
		

		
			Email Address of Authorized Signatory:       xxxxx@xxxx.com        
		

		
			﻿
		

		
			[Purchaser Signature Page to Securities Purchase Agreement]
		

		

		

		 

		

			 

		

 

		

			 

		

		
		

		
			IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.
		

		
			 
		

		
			Name of Purchaser:    CVI Investments, Inc. by: Heights Capital Management, Inc. its authorized agent         
		

		
			Signature of Authorized Signatory of Purchaser:        /s/ Martin Kobinger             
		

		
			Name of Authorized Signatory:        Martin Kobinger         
		

		
			Title of Authorized Signatory:         Investment Manager                 
		

		
			Email Address of Authorized Signatory:       xxxxx@xxxx.com        
		

		
			﻿
		

		
			[Purchaser Signature Page to Securities Purchase Agreement]
		

		
			﻿
		

		

		

		 

		

			 

		

 

		

			 

		

		
		

		
			IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.
		

		
			 
		

		
			Name of Purchaser:    Alyeska Master Fund, L.P.      
		

		
			Signature of Authorized Signatory of Purchaser:        /s/ Jason Bragg                      
		

		
			Name of Authorized Signatory:        Jason Bragg
		

		
			Title of Authorized Signatory:         CFO and CCO, Alyeska Investment Group, L.P.                    
		

		
			Email Address of Authorized Signatory:       xxxxx@xxxx.com        
		

		
			﻿
		

		
			[Purchaser Signature Page to Securities Purchase Agreement]
		

		

		

		 

		

			 

		

 

		

			 

		

		
		

		
			IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.
		

		
			 
		

		
			Name of Purchaser:    Alyeska Master Fund 2, L.P.  
		

		
			Signature of Authorized Signatory of Purchaser:        /s/ Jason Bragg                      
		

		
			Name of Authorized Signatory:        Jason Bragg               
		

		
			Title of Authorized Signatory:         CFO and CCO, Alyeska Investment Group, L.P.                    
		

		
			Email Address of Authorized Signatory:       xxxxx@xxxx.com        
		

		
			﻿
		

		
			[Purchaser Signature Page to Securities Purchase Agreement]
		

		

		

		 

		

			 

		

 

		

			 

		

		IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.
		

		
			 
		

		
			Name of Purchaser:    Rock Springs Capital Master Fund LP 
		

		
			By: Rock Springs General Partner LLC         
		

		
			Signature of Authorized Signatory of Purchaser:        /s/ Mark Bussard                     
		

		
			Name of Authorized Signatory:        Mark Bussard                     
		

		
			Title of Authorized Signatory:         Managing Member
		

		
			Email Address of Authorized Signatory:       xxxxx@xxxx.com        
		

		
			﻿
		

		
			[Purchaser Signature Page to Securities Purchase Agreement]
		

		

		

		 

		

			 

		

 

		

			 

		

		
		

		
			IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.
		

		
			 
		

		
			Name of Purchaser:    Grandeur Peak Global Advisors, LLC         
		

		
			Signature of Authorized Signatory of Purchaser:        /s/ Eric Huefner                      
		

		
			Name of Authorized Signatory:        Eric Huefner                
		

		
			Title of Authorized Signatory:         President                    
		

		
			Email Address of Authorized Signatory:       xxxxx@xxxx.com        
		

		
			﻿
		

		
			[Purchaser Signature Page to Securities Purchase Agreement]
		

		
			﻿
		

		
			﻿
		

		
			Grandeur Peak Global Advisors, LLC, on behalf of
		

			
	
			
				 ·
			

			
	
			
			Grandeur Peak Global Opportunities Fund

			
	
			
				 ·
			

			
	
			
			Grandeur Peak Global Opportunities, L.P.

			
	
			
				 ·
			

			
	
			
			Grandeur Peak Global Reach Fund

			
	
			
				 ·
			

			
	
			
			Grandeur Peak Global Micro Cap Fund

		
			﻿
		

		
			﻿
		

		

		

		 

		

			 

		

 

		

			 

		

		
		

		
			IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.
		

		
			 
		

		
			Name of Purchaser:    FTIF – Franklin Biotechnology Discovery Fund_(4912) By: Franklin Advisers, Inc. its investment manager         
		

		
			Signature of Authorized Signatory of Purchaser:        /s/ Evan McCulloch                      
		

		
			Name of Authorized Signatory:        Evan McCulloch
		

		
			Title of Authorized Signatory:         Vice President                    
		

		
			Email Address of Authorized Signatory:       xxxxx@xxxx.com        
		

		
			﻿
		

		
			[Purchaser Signature Page to Securities Purchase Agreement]
		

		
			﻿
		

		

		

		 

		

			 

		

 

		

			 

		

		IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.
		

		
			 
		

		
			Name of Purchaser:    FSS – Franklin Biotechnology Discovery Fund (4402) By: Franklin Advisers, Inc. its investment manager        
		

		
			Signature of Authorized Signatory of Purchaser:        /s/ Evan McCulloch                      
		

		
			Name of Authorized Signatory:        Evan McCulloch  
		

		
			Title of Authorized Signatory:         Vice President                    
		

		
			Email Address of Authorized Signatory:       xxxxx@xxxx.com        
		

		
			﻿
		

		
			[Purchaser Signature Page to Securities Purchase Agreement]
		

		

		

		 

		

			 

		

 

		

			 

		

		IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.
		

		
			 
		

		
			Name of Purchaser:    On behalf of:   Special Situations Fund III QP, LP
		

		
			Special Situations Cayman Fund, LP
		

		
			Special Situations Life Sciences Fund, LP
		

		
			Signature of Authorized Signatory of Purchaser:        /s/ Adam Stettner                     
		

		
			Name of Authorized Signatory:        Adam Stettner                                        
		

		
			Title of Authorized Signatory:         Partner                    
		

		
			Email Address of Authorized Signatory:       xxxxx@xxxx.com        
		

		
			﻿
		

		
			[Purchaser Signature Page to Securities Purchase Agreement]
		

		
			﻿
		

		

		

		 

		

			 

		

 

		

			 

		

		IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.
		

		
			Name of Purchaser:    Broadfin Healthcare Master Fund, Ltd.
		

		
			Signature of Authorized Signatory of Purchaser:        /s/ Kevin Kotler                     
		

		
			Name of Authorized Signatory:        Kevin Kotler                                     
		

		
			Title of Authorized Signatory:         Director                    
		

		
			Email Address of Authorized Signatory:       xxxxx@xxxx.com        
		

		
			﻿
		

		
			[Purchaser Signature Page to Securities Purchase Agreement]
		

		
			 
		

		

		

		 

		

			 

		

 

		

			 

		

		Schedule A
		

		
			﻿
		

			
					
						﻿

					
					
						 

					
					
						 

				
	
					
						Purchaser

					
					
						Number of Shares

					
					
						Subscription Amount

				
	
					
						Alyeska Master Fund, L.P.

					
					
						469,697

					
					
						$2,465,909.00

				
	
					
						Alyeska Master Fund 2, L.P.

					
					
						305,303

					
					
						$1,602,841.00

				
	
					
						Broadfin Healthcare Master Fund, Ltd.

					
					
						760,000

					
					
						$3,990,000.00

				
	
					
						CVI Investments, Inc.

					
					
						725,000

					
					
						$3,806,250.00

				
	
					
						Deutsche Asset Management (DWS US Growth)

					
					
						90,000

					
					
						$472,500.00

				
	
					
						EcoR1 Capital Fund Qualified, LP

					
					
						502,830

					
					
						$2,639,857.50

				
	
					
						EcoR1 Capital Fund, LP

					
					
						147,170

					
					
						$772,642.50

				
	
					
						FTIF – Franklin Biotechnology Discovery Fund_(4912)

					
					
						502,000

					
					
						$2,635,500.00

				
	
					
						FSS – Franklin Biotechnology Discovery Fund (4402)

					
					
						198,000

					
					
						$1,039,500.00

				
	
					
						Grandeur Peak Global Micro Cap Fund

					
					
						2,625

					
					
						$13,781.25

				
	
					
						Grandeur Peak Global Opportunities Fund

					
					
						85,825

					
					
						$450,581.25

				
	
					
						Grandeur Peak Global Opportunities, L.P.

					
					
						30,925

					
					
						$162,356.25

				
	
					
						Grandeur Peak Global Reach Fund

					
					
						35,625

					
					
						$187,031.25

				
	
					
						Janus Capital Funds Plc – Janus Venture Fund

					
					
						21,558

					
					
						$113,179.50

				
	
					
						Janus Investment Fund – Janus Venture Fund

					
					
						321,440

					
					
						$1,687,560.00

				
	
					
						Ohio National Fund, Inc. – Small Cap Growth Portfolio

					
					
						27,002

					
					
						$141,760.50

				
	
					
						Rock Springs Capital Master Fund LP

					
					
						250,000

					
					
						$1,312,500.00

				
	
					
						Special Situations Fund III QP, LP

					
					
						288,750

					
					
						$1,515,937.50

				
	
					
						Special Situations Cayman Fund, LP

					
					
						94,500

					
					
						$496,125.00

				
	
					
						Special Situation Life Sciences Fund, LP

					
					
						141,750

					
					
						$744,187.50

				
	
					
						Total

					
					
						5,000,000

					
					
						$26,250,000

				

		
			﻿

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00270-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00270-of-00352.parquet"}]]